Abstract
Introduction

29
Gene transcription by RNA polymerase II (Pol II) is essential for all kingdoms of life and involves three 30 distinct phases: initiation, elongation and termination. Transcription elongation proceeds through an 31 iterative cycle of substrate selection, catalysis of phosphodiester bond formation, and enzyme 32 translocation [Reviewed in [1, 2] ]. Pausing, backtracking, and arrest of Pol II can occur during 33 elongation. Pol II elongation factors are proposed to promote Pol II elongation by modulating these 34 processes or otherwise enabling Pol II to overcome obstacles. Coordinated with elongating Pol II, 35 several co-transcriptional events occur to control the fate of nascent RNAs and ensure proper gene 36 expression [Reviewed in [3] ]. Thus, it is likely that perturbation of Pol II elongation will have multi-faceted 37 effects on co-transcriptional processes and overall gene expression. To understand the complexity of 38
Pol II activity-mediated control of gene expression it is necessary to understand how alteration of Pol II 39 catalytic activity relates to specific gene expression defects. 40
Studies from our lab and others have identified several Pol II catalytic mutants that can alter elongation 41 rate in vitro [4] [5] [6] . Based on these mutants' ability to increase or decrease transcription elongation rate 42 relative to wild type (WT), we term them "gain of function" (GOF) or "loss of function" (LOF) mutants, 43
respectively [4] . Most of these mutants reside in a highly conserved, mobile sub-domain known as the 44 trigger loop (TL) [4] [5] [6] . The TL is a component of the Pol II catalytic center, and can directly interact with 45 incoming NTPs, undergoing conformational changes to promote rapid catalysis [5, 7, 8] . TL mutants 46 have been shown to affect a number of Pol II biochemical properties including catalysis, substrate 47 selection and transcription fidelity [5, 8] . In addition, TL mutants have been also shown to affect Pol II 48 translocation, pausing and intrinsic cleavage properties [9] [10] [11] . 49
The rate of transcription elongation has likely evolved to facilitate co-transcriptionality, which enhances 50 the efficiency of pre-mRNA processing and maturation [Reviewed in [3] ]. Maturation of pre-mRNA 51 requires addition of a 7-methyl guanosine cap at the 5'-end of the transcript, splicing of introns, and 52 addition of a poly(A) tail to the 3'-end of the transcript. Further, the pre-mRNA is uniquely packaged with 53 protein components into a mature mRNA granule, which facilitates export and efficient translation. 54
Impaired processing leads to degradation of pre-mRNAs by nuclear surveillance pathways. Mechanistic 55 coupling of transcription and pre-mRNA processing is achieved through recruitment of factors by C-56 terminal domain (CTD) and by kinetic competition [Reviewed in [3] ]. Using Pol II catalytic mutants, it has 57 been shown that kinetic competition may govern pre-mRNA splicing and polyadenylation [12] [13] [14] [15] [16] . At 58 least one Pol II catalytic mutant has been reported to be defective in 5'-capping, leading to the 59 degradation of transcript by 5' to 3' nuclear exonuclease [17] . Additionally, a number of findings suggest 60 kinetic competition between transcription termination and elongation in both yeast and human cells [18, 61 19] . Recently, a competition-independent pathway has been proposed for termination that occurs 62 through a conformational change to Pol II [20] . Furthermore, evidence has led to proposals about 63 connections between transcription rate and mRNA decay to maintain cellular mRNA abundance, though 64 molecular mechanisms are unclear [21] [22] [23] [24] [25] . For example, growth rate is also proposed to control mRNA 65 decay and overall mRNA abundance, but whether mutants' effects on transcription rate or their effects 66 on growth are the major contributing factors in alteration of mRNA decay is unknown [26] [27] [28] . 67
In order to study Pol II elongation in vivo, a number of methods have been implemented that either 68 directly measure apparent Pol II elongation rate or determine indirect consequences of elongation rate 69 [29] [30] [31] [32] (for a list methods and estimated in vivo Pol II elongation rate see here [33] ). Two methods are 70 generally used to study elongation in yeast, one to study elongation properties and the other to 71 genetically implicate factors in elongation control. The first utilizes chromatin immunoprecipitation (ChIP) 72 to determine Pol II occupancy across a long galactose-inducible gene, GAL1p::YLR454w, either in 73 steady state or after transcription shut off by addition of glucose [29] . Apparent processivity is inferred 74 from comparison of steady state Pol II occupancy for wild type and transcription mutants, while kinetics 75 of the 'last wave' of Pol II leaving the template can be used to determine the apparent elongation rate 76 (Supplementary Table 1 ). Indeed, Pol II catalytic mutants and several factors mutants have shown 77 altered apparent in vivo elongation rate and apparent processivity defects in this assay. Processivity can 78 only be inferred, because differential elongation rate over regions of the template may also explain 79 differential occupancy. Interpretation of apparent elongation rate differences based on transcriptional 80 shut off makes assumptions that signaling and kinetics of the shut off are identical between WT and 81 mutant strains. Similarly, in a second widely used approach, genetic detection of elongation defects 82 through use of nucleotide-depleting drugs makes assumptions that drug effects are identical between 83
WT and mutant strains, and this issue is discussed below. 84
Nucleotide-depleting drugs, such as mycophenolic acid (MPA), which limits cellular GTP levels by 85 inhibiting IMPDH activity, are assumed to elicit transcription elongation defects by enhancing pausing, 86
arrest, or backtracking due to limitation in substrate levels [1, [34] [35] [36] [37] . Growth sensitivity to MPA for Pol II 87 or presumptive elongation factor mutants has been widely interpreted as a synergistic effect between 88 MPA treatment and impaired elongation due to the mutant. The notion that limiting nucleotide is the 89 major determinant of drug phenotypes was further strengthened by the observation that guanine 90 supplementation suppresses sensitivity to the drug, along the observation of elongation defects due to 91 drug treatment [29, 38] 
Chromatin immunoprecipitation 141
All the strains used for ChIP experiments contained a C-terminal epitope tag on the Rpb3 subunit of 142 RNA Pol II (RPB3::3XFLAG::KANMX; see strain list). ChIP experiments were performed as described 143 previously [45] . Briefly, 100 ml of mid-log phase cells (~1x10 7 cells/ml) were cross-linked with 1% 144 formaldehyde (final) for 20 min, and then quenched with 15 ml of 2.5 M glycine for 5 min. Cross-linked 145 cells were washed twice with cold 1X TBS buffer at 4˚C and were disrupted by bead beating with glass 146 beads in lysis buffer (0.1 M Tris pH 8.0, glycerol 20%, 1 mM PMSF). Cross-linked cell lysates were 147 subjected to a low speed spin (1500 rpm, 1 min at 4˚C) to remove cell-debris, followed by centrifugation 148 of chromatin pellets, subsequent washing of pellets (twice) with 1 ml FA buffer (50 mM HEPES-KOH pH 149 7.5, 300 mM NaCl, 1 mM EDTA, 0.1% Triton X-100, 0.01% sodium deoxycholate, 0.1% SDS and 1 mM 150 PMSF) at 14000 rpm for 20 min at 4˚C. Chromatin pellets were resuspended in 1 ml of FA buffer and 151 sonicated at 4˚C using a Diagenode Bioruptor (45 cycles -3 x 15 cycles; 30 sec ON/ 45 sec OFF) to 152 generate ~300-500 bp chromatin fragments (verified on 1% agarose gel 
Microscopy and image analysis 219
Mig1p-GFP tagged strain was made by integrating GFP C-terminal tag at the genomic locus (see strain 220 description). Microscopy was performed as described previously [50] , with modifications. Briefly, cells 221 grown overnight in SC medium (2% galactose) at 30˚C, diluted in fresh SC media and grown till mid-log 222 at 30˚C before microscopy. Perfusion chamber gasket (ThermoFisher, 4 chamber: 19 mm X 6 mm) was 223 used for changing medium. Chamber was treated with Con A (2 mg/ml, MP Biomedicals) for 10-15 min, 224 and then cells were injected into the chamber and allowed 10-15 min to adhere. Medium exchange from 225 SC (2% galactose) to SC (2% galactose) + glucose (4% final) was done by pipetting quickly, while the 226 chamber is fixed on the microscope stage. Pre-glucose sample was considered as time 0 and glucose 227 repression time points were taken immediately after exchange of the medium. 228
For Mig1p-GFP nuclear localization kinetics, microscopy was performed with an inverted 229 epifluorescence microscope (Ti-E, Nikon, Tokyo, Japan) using a 100x objective (Plan Fluo, NA 1.40, oil 230 immersion) and standard filter sets. Images were acquired using a cooled EMCCD camera (iXon3 897, 231
Andor, Belfast, United Kingdom). For delayed Mig1p response (longer time points), microscopy was 232 performed with a Nikon Ti-E microscope equipped with a CFI Plan Apo lambda DM 100x objective and a 233
Prior Scientific Lumen 200 Illumination system. All images were acquired using NIS Element software 234 and data analysis was done using Quantity One (Bio-Rad). Ratio of nuclear/cytoplasmic GFP intensity 235 was calculated as [(nuclear GFP intensity -background) / (cytoplasmic GFP intensity -background)]. 236
Obtained values for glucose repression time points were normalized to pre-glucose (time 0, t0) value. 237
Non-responding cells were quantified similarly, except for the fact that there was no visible nuclear foci, 238 thus a random, central area was selected and measured for fluorescence intensity. Position and area of 239 the measurement was kept identical for all the time points for the same cell. We reasoned that a non-240 responding cell would not have a distinct change over time in nuclear/cytoplasmic GFP intensity, hence 241 quantifying a random area as nucleus should not have an overall affect on the interpretation of the data. 242 243
RESULTS
244
Pol II catalytic mutants alter steady state Pol II occupancy and apparent processivity. 245
Previously we reported genetic and biochemical dissection of Pol II catalytic mutants as probes for 246 transcription mechanisms [4, 5, 51] . To explore in vivo consequences of altered Pol II activity, we 247 examined Pol II occupancy by chromatin IP for a subset of LOF and GOF Pol II mutants over a widely 248 used inducible long reporter gene, GAL1p::YLR454w ( Figure 1A and [29]). We observed decreased 249 overall polymerase occupancy for GOF and LOF mutants compared to WT ( Figure 1B) . Among the 250 mutants tested, H1085Y (strong LOF) and G1097D (strong GOF) showed the most severe defects in Pol 251 II occupancy, consistent with their severe growth defects in vivo [4] . A number of polymerase and 252 transcription associated factor mutants confer reduced Pol II occupancy over the 3' end of 253
GAL1p::YLR454w, and this defect has been previously interpreted as a defect in Pol II processivity [29] . 254
When we normalized the Pol II fold-enrichment over the 5' end of the gene body ("1kb" amplicon) 255
followed by normalization of mutant values to WT, catalytic mutants show selective decrease in 256 occupancy over the 3' end of the reporter (most obvious for G1097D) ( Figure 1C ). While decreased Pol 257 II occupancy is consistent with a gradient of Pol II dissociation or degradation across a transcription unit, 258 it is also consistent with alterations in Pol II elongation rate over gene bodies as have been observed in 259 mammalian cells [52] [53] [54] . ChIP is unable to distinguish between the two possibilities. 260
Additional factors may determine Pol II occupancy levels over genes. For example, Pol II occupancy 261 over a template can be gene class-dependent or regulon-specific, and external perturbations such as 262 changes in temperature or carbon source can affect transcription [55, 56] . Here we examined Pol II 263 occupancy over the same reporter driven by a constitutive promoter (TEF1p::YLR454w) for the most 264 severely defective Pol II LOF and GOF mutants grown in glucose-or galactose-containing medium 265
( Figure 1D and E). In contrast to GAL1p::YLR454w occupancy, here we observed a increased Pol II 266 occupancy for H1085Y in galactose relative to glucose, with the converse for G1097D, compared to WT 267 (Figure1E), although, a 3' occupancy defect was still apparent for both mutants. Further, G1097D 3' 268 occupancy defect appeared to be less severe in galactose compared to glucose, suggesting this 269 particular mutant or, this class of mutants may behave differently in glucose and galactose. WT Pol II 270 showed more subtle changes in occupancy in glucose relative to galactose. 271
Pol II catalytic mutants alter reporter gene expression with exacerbating effect of increasing gene 272 length and promoter strength. 273
Decreased Pol II occupancy for some mutants could be explained by increased elongation rate, leading 274 to reduced steady state levels of Pol II on genes. Alternatively, defective initiation or elongation might 275 . CC-BY-NC-ND 4.0 International license peer-reviewed) is the author/funder. It is made available under a
The copyright holder for this preprint (which was not . http://dx.doi.org/10.1101/072785 doi: bioRxiv preprint first posted online Aug. 31, 2016;  lead to decreased Pol II occupancy [57] . Pol II activity mutants do perturb initiation as most or all show 276 defects in TSS selection [14, 51] . Mutants affecting Pol II elongation also have been shown to affect 277 reporter gene expression depending on nature of transcription unit driven by identical promoters, 278 allowing presumptive elongation defects to be distinguished from initiation defects, using the so-called 279 GLAM assay [32, 58] . To determine how Pol II catalytic mutants affect gene expression, and expression 280 defects relate to gene length and/or promoter strength, we measured effects on expression of YLR454w 281 (in different promoter contexts), endogenous TEF1, and endogenous GAL1 by northern blotting ( Figure  282 2A and B). We observed strong effects on GAL1-YLR454w expression in Pol II mutants compared to 283 WT, with the magnitudes of effects higher than for defects in occupancy, especially for H1085Y and 284 G1097D. Although the expression defect in H1085Y can be explained by slow elongation based on its in 285 vitro elongation rate, results for G1097D and E1103G, predicted to be fast for elongation, suggest they 286 have occupancy defects for reasons other than merely being fast in vivo. 287
Furthermore, we determined that Pol II catalytic mutants show greater gene expression defects for 288 GAL1-YLR454w than for the more lowly expressed TEF1-YLR454w. We also examined native TEF1 and 289 GAL1 expression levels in Pol II mutants and found greater expression defects for the longer YLR454w 290 transcription unit versus the native transcription units, and for more highly expressed promoters relative 291 to promoters generating lower expression levels. These results are consistent with previous 292
observations showing Pol II occupancy and gene length dependent effects of reporter expression for 293 several elongation mutants [32, 58] . Given reduced Pol II occupancy and gene expression, it is likely that 294 initiation defects might also be in play, especially due to the fact that all Pol II catalytic mutants tested 295
here show defects in TSS selection [14, 51] . Examination of the activation kinetics for GAL1p::YLR454w 296 or GAL1 revealed delayed induction for Pol II catalytic mutants, consistent with defects in activation or 297 initiation ( Figure 2C) . 298
Pol II catalytic mutants show allele-specific genetic interactions with pre-mRNA processing 299 factors. 300
Eukaryotic mRNA processing includes the addition of a 5' cap and a 3'-poly(A) tail that protects mRNA 301 from degradation by 5' exonucleases and 3' exonucleases, respectively. While mRNA degradation 302 predominantly occurs in cytoplasm, dedicated exonucleases are present in the nucleus for surveillance 303 and degradation of defective, improperly packaged, or prematurely terminated RNAs. We reasoned that 304 an mRNA processing defect or premature termination could lead to degradation of pre-mRNA by 5' or 3'-305 exonucleases, respectively, resulting in decreased abundance of GAL1-YLR454w. We first determined if 306
Pol II mutants showed genetic interactions with known exonucleases that function in surveillance. 307
Deletion of Rrp6, a component of the 3'-exonuclease exosome complex, showed a slight negative 308 genetic interaction with Pol II GOF mutants ( Figure 3A) . Inactivation of Rat1 and Xrn1, two 5'-309 exonucleases, showed strong genetic interactions with GOF mutants ( Figure 3A) . Rat1 is essential and 310 functions in termination of Pol II at protein-coding genes [59, 60] . LOF mutants partially suppressed the 311 Ts -phenotype of rat1-1, a conditionally viable allele of RAT1. In contrast, GOF Pol II alleles showed 312 synthetic sick interactions with rat1-1, consistent with prior findings and model proposed for kinetic 313 competition between termination and elongation [18, 19, 61] . Rat1 works with an activating partner Rai1, 314 which processes partially capped mRNA allowing Rat1 access [62] . Growth defect of rai1∆ was slightly 315 suppressed by both LOF and GOF mutants at 37˚C, while dxo1∆, a recently described nuclear 5'-316 exonuclase [63] , showed no strong genetic interactions with Pol II alleles ( Figure 3A) . 317
We then asked if mRNA processing mutants that show genetic interactions with Pol II mutants were able 318 to modulate Pol II alleles' gene expression defects. As expected, deletion of Rrp6 did not recuse full-319 length GAL1p::YLR454w expression level significantly; the nuclear exosome would be expected to 320 mainly degrade prematurely-terminated transcripts (Supplementary Figure 1A) . Deletion of Xrn1 321 slightly rescued GAL1p::YLR454w expression level in E1103G, while inactivation of Rat1 severely 322 decreased GAL1p::YLR454w expression level in both WT and catalytic mutants possibly due its growth 323 defect (Supplementary Figure 1A and B) . We found that xrn1∆/rat1-1 double mutant strains were 324 extremely sick on YPGal even at permissive temperature (Supplementary Figure 1C) . The abundance of cellular mRNAs is determined by synthesis and degradation rates. In order to 336 determine if the Pol II mutants altered half-life of the GAL1p::YLR454w mRNA, we performed 337 transcriptional shut off by addition of glucose followed by measurement of mRNA over time by northern 338 blotting. mRNA half-lives were determined by fitting decay curves with a lag followed by exponential 339 decay (Supplementary Figure 2A) . The observed lags comprise the cellular response time for 340 transcriptional shut off, the time for engaged Pol II to run off the gene, and the time for mRNA to be 341 exported from the nucleus as the major mRNA decay pathways are cytoplasmic. Such lags have been 342 observed in genome-wide experiments that block initiation and allow elongation to proceed [65] . We 343 found that all GOF and LOF mutants conferred an increase in the half-life of YLR454w, in addition to 344
showing longer lag periods compared to WT ( Figure 4A, Supplementary Figure 2B- Figure 5A ) [29] . As 363 predicted, LOF mutants N479S and H1085Y showed extensive delay compared to WT in Pol II run-off 364 kinetics subsequent to transcriptional shutoff by the addition of glucose to the medium ( Figure 5B and 365 D). The apparent in vivo elongation rate of H1085Y was slower than N479S, which is consistent with its 366 stronger growth defects and in vivo phenotypes relative to N479S. This is in slight contrast to previous in 367 vitro measurements indicating N479S Pol II as slower than H1085Y. However, in direct contrast to 368 previous observations and predictions, both the GOF mutants tested here, E1103G and G1097D, also 369 showed reduced kinetics of Pol II runoff subsequent to glucose shut off ( Figure 5C ). This result was 370 unexpected, especially when E1103G seemed to have faster elongation rate than WT in this assay [18] . 371
Furthermore, analogous substitution in human POLR2A E1126G confers a slightly faster than WT 372 elongation rate in vivo [12] . It is important to note that there are distinctions between glucose shut off 373 protocols used by us and by Hazelbaker et al [18] . In order to understand the nature of the observed 374 discrepancy, we first confirmed our GOF mutant strains by three steps -i. confirmation of the mutation 375 by sequencing, ii. transcriptional growth phenotypes as described in [4] , and iii. mutants ability to shift 376 transcriptional start sites (TSSs) at the ADH1 promoter as described in [4, 14, 51] (Supplementary 377 Figure 3A) . In all cases, results were consistent with correct strains showing expected phenotypes. In 378 addition, we analyzed the SNR33 termination window in these mutants. It has been proposed that kinetic 379 competition between elongating Pol II and Sen1 helicase determines the termination of the snR33 380 transcript [18] . Deletion of the nuclear exosome subunit Rrp6 stabilizes pre-processed snR33 381 intermediate transcripts allowing detection of the snR33 termination window by examination of snR33 382 transcript length ( Figure 6A ). Both GOF mutants E1103G and G1097D increase the average length of 383 31, 2016; pre-processed snR33, which is in agreement with previous observations for E1103G (Figure 6B and 384 [18] ). Conversely, LOF mutants N479S and H1085Y decreased the average length of pre-processed 385 snR33 ( Figure 6B ). Average length of pre-processed snR33 is longer in G1097D than E1103G, 386 consistent with faster in vitro elongation rate of G1097D than E1103G, and is shorter in H1085Y than 387 N479S, consistent with slower apparent in vivo elongation rate shown in this study ( Figure 5D ). We also 388 observed alternative mature snR33 transcripts longer or shorter in length for GOF and LOF mutants, 389 respectively, consistent with increased upstream or downstream utilization of transcription start site 390 (TSS) in these mutants. 391
Next, we measured the in vivo elongation rate for E1103G using the protocol as described in Hazelbaker 392 et al [18] , with one important addition. The prior study utilized a no sugar wash between growth in 393 galactose and resuspension of cells in glucose-containing medium. Our addition was to take a time point 394 just post wash (W0) to determine if this wash step was neutral in regards to Pol II occupancy, in addition 395 to the pre-wash "zero" used by Hazelbaker et al [18] . In our hands, E1103G was slower exiting the 396 template than WT, consistent with our direct glucose shut off without washing, and our measurement of 397 increased lag prior to exponential RNA decay following shutoff of this mutant ( Figure 5E ). Furthermore, 398
Pol II occupancy at the W0 time point shows evidence of transcriptional shutoff due to absence of sugar 399 during the wash, indicating that any variability in duration of this step would have effects on 400 determination of presumptive elongation rates. We confirmed the observed decrease in Pol II occupancy 401
is not due to delayed formaldehyde cross-linking, as we did not observe any difference in Pol II 402 occupancy when crosslinking was simultaneous with the addition of glucose (Supplementary Figure  403  3B ). E1103G Pol II exhibits a loss of occupancy over the 3'-end of GAL1p::YLR454w compared to WT 404 following the no sugar wash that was not observed when transcription was shut off with addition of 405 glucose ( Figure 5C and 5E). In order to examine this further, we performed a galactose starvation time 406 course where no sugar was added. This experiment showed similar 3' specific runoff in E1103G early in 407 the time course, and not seen under glucose shutoff ( Figure 5F ). As polymerases (presumptively) run 408 into the gene 3' end at later time points, the effect diminishes. Additionally, in this iteration of the 409 experiment there appears to be faster loss of E1103G from the 5' end of the reporter early, though 410 E1103G is maintained much longer later in the time course ( Figure 5F ). 411
Glucose repression signaling involving Mig1 nuclear translocation is aberrant in Pol II GOF 412 mutants 413
One possibility for apparent slower elongation of GOF mutants on the GAL1p::YLR454w template could 414 be delayed transcriptional shut off. We reasoned that if glucose-repression were delayed in GOF 415 mutants, it would contribute to apparent slow kinetics of Pol II exiting the gene. To this end, we 416 investigated the kinetics of nuclear localization of Mig1p, which upon addition of glucose to medium is 417 imported into the nucleus due to regulation by dephosphorylation, binds to target promoters of glucose-418 repressed genes and recruits co-repressors [66, 67] . As a proxy for early events in this cascade, we 419 determined the kinetics of Mig1p nuclear localization by monitoring import of Mig1p-GFP upon glucose 420 addition in WT or GOF catalytic mutants [50] . We observed the concentration of Mig1p fluorescence 421 signal (presumably localizing to the nucleus) saturate within ~2 min for WT cells, as previously reported 422
[68]. However, the GOF mutants did not appear to reach maximum nuclear fluorescence within 2 min of 423 glucose addition, thus we measured extended time points and analyzed the data using non-linear 424 regression ( Figure 7A and B) . G1097D showed both a delay in average time of Mig1p nuclear import 425 and reduced average maximum nuclear fluorescence compared to WT, suggesting at least in this 426 mutant in vivo shut off kinetics may be delayed due to deranged Mig1p signaling ( Figure 7B ). When we 427 measured extended time points, a noticeable subset of delayed responding cells was observed again for 428 G1097D, while higher fractions of non-responding cells were observed for both E1103G and 429 G1097D. (Figure 7C and Supplementary Figure 4 To evaluate how Pol II responds to GTP starvation and determine whether Pol II transcription is a critical 439 determinant for cellular sensitivity to GTP starvation, we employed a strategy to normalize GTP 440 starvation upon MPA treatment across strains by deletion of IMD2 (Figure 8) . To enable an in vivo 441 readout for IMD2 expression, we replaced the IMD2 ORF with HIS3 ( Figure 8A) . 442
In the absence of IMD2, yeast strains become hypersensitive to MPA treatment as expected ( Figure 8B ) 443 [69, 70] . If Pol II transcription were a major determinant of GTP starvation, relative to all other cellular 444 GTP-dependent processes, it would be predicted that elongation-defective Pol II alleles would be 445 additionally hypersensitive to MPA, while increased catalytic activity mutants would be resistant. In 446 contrast to these predictions, deletion of IMD2 strongly blunts the Pol II allele-specific effects of MPA 447 treatment on yeast cells ( Figure 8B ). We do in fact observe very mild MPA sensitivity for Pol II GOF 448 alleles, but these effects are counter to expectations of the widely presented model for Pol II response to 449 GTP starvation. These results suggest that the major determinant for Pol II allele sensitivity to MPA is 450 differential IMD2 expression, and that Pol II transcription is not a major determinant for sensitivity to GTP 451 starvation in the absence of IMD2. MPA effects are presumed to function through GTP starvation as 452 indicated by suppression of sensitivity upon addition of guanine to the growth medium, allowing an 453 alternate route for GTP synthesis. In testing this presumption, we found that addition of 10 mM NaOH to 454 medium on its own abrogated any MPA effects, likely through alteration of MPA solubility 455 (Supplemental Figure 5) . Furthermore, Pol II mutants show allele-specific phenotypes upon change to 456 pH of media [10] . As basic conditions are required for guanine solubility in stock solutions, this 457 confounds previous interpretations where pH effects of guanine addition, or on mutant phenotypes, were 458 not controlled. We determined that addition of guanine/NaOH or NaOH alone to medium, followed by 459 neutralization of NaOH with equivalent HCl, with subsequent MPA addition allowed for both MPA and 460 guanine to coexist in media ( Figure 8B ). We observed almost but not complete suppression of MPA by 461 addition of guanine, with mild sensitivity of GOF mutants to MPA in the presence of guanine. These 462 results suggest that either the IMD2-independent MPA effects on GOF mutants are independent of GTP 463 starvation, or these mutants have alterations in their GTP salvage synthesis pathways. 464
We next determined if the ability to induce the IMD2 promoter was maintained in Pol II mutants when 465 GTP starvation conditions were normalized, using growth on medium lacking histidine to detect 466 expression of imd2∆::HIS3 ( Figure 8C) we characterized these strains' sensitivity to MPA treatment in the absence of IMD2 (Figure 9) . We 480 observed a wide range of behaviors for these strains in presence or absence of IMD2 ( Figure 9A) . First, 481 not all were sensitive to MPA. Second, only spt3∆ maintained MPA hypersensitivity in the absence of 482 IMD2 relative to WT, while dst1∆ showed only slight sensitivity relative to WT. We next examined 483 suppression of observed MPA sensitivities by guanine supplementation ( Figure 9A , bottom panels). We 484 observed that spt3∆ was entirely suppressed by guanine, dst1∆ mostly suppressed, and spt4∆, paf1∆, 485 and gal11∆ much less so. We hypothesize that spt3∆ hypersensitivity relates to defects in TPO1 486 expression, as shown previously. TPO1 encodes a transporter known to modulate MPA sensitivity [38] . 487
Conversely, other factors can show sensitivity to MPA even in the presence of guanine. Taken together, 488 these results are inconsistent with putative global Pol II transcription defects being a critical determinant 489 for cell growth under GTP limitation. 490 .
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The copyright holder for this preprint (which was not . http://dx.doi.org/10.1101/072785 doi: bioRxiv preprint first posted online Aug. 31, 2016;  We further examined if IMD2 promoter function in response to MPA were intact in the cohort of 491 transcription factor mutants tested ( Figure 9B GTP starvation in vivo relative to other pathways that rely on GTP (Figure 8 and 9) . To better 505 understand the mechanism of IMD2 expression defects in the absence of differential GTP starvation, we 506 further analyzed transcriptional responses at the IMD2 promoter upon MPA treatment. Using the same 507 imd2∆::HIS3 reporter construct used above, we analyzed the kinetics of TSS utilization upon addition of 508 a concentration of MPA that induces a TSS shift at the IMD2 promoter ( Figure 10A ). Pol II has been 509 proposed to directly sense GTP levels through its active site, and through this sensing Pol II catalytic 510 activity controls IMD2 TSS usage [41] . Under this model, it would be predicted that LOF Pol II mutants 511 might show precocious downstream TSS usage; indeed, this behavior has previously been observed [4] . 512
Conversely, catalytically GOF Pol II mutants would show delayed TSS shifting kinetics due to their 513 relative insensitivity to reduced GTP levels. 514
We observed that both LOF (H1085Y) and GOF (E1103G) mutants gradually lose upstream 'G' sites 515 (Figure 10B ), indicating retention of ability to respond to GTP-depletion. As expected WT cells rapidly 516 lose upstream 'G' TSSs and subsequently gain the downstream functional 'A' TSS ( Figure 10C ). 517 H1085Y constitutively uses the downstream functional 'A' TSS and shows increased usage of this site 518 upon GTP depletion, while still showing decreased kinetics of loss of upstream TSSs. This result is 519 unexpected from the "defective GTP sensing" model (Fig 10 B and C) . E1103G shows reduced kinetics 520 of loss of upstream site, consistent with defective GTP sensing, but shifts TSS usage to novel TSSs 521 predicted to be nonfunctional due to their position upstream of the IMD2 Nab3/Nrd1-dependent 522 terminator ( Figure 10B and C) . If terminated by the Nab/Nrd pathway, putative non-functional novel 523
TSSs should produce CUTs that are degraded by the nuclear exosome [78, 79] . Indeed, deletion of 524 exosome subunit Rrp6 stabilized these transcripts derived from these novel TSSs, with significant 525 utilization of these TSSs in E1103G compared to WT ( Figure 10D and Supplementary Figure 6A-B) . 526
As expected these non-functional CUTs did not provide MPA resistance in sensitive GOF mutants 527 (Supplementary Figure 6C) . We note that although E1103G generally appears unable to utilize 528 downstream functional 'A' TSS upon MPA treatment, enough functional transcript is made to produce 529 the observed His + phenotype at low concentrations of MPA treatment ( Figure 9B) . 530
531
Discussion
533
Examination of Pol II catalytic mutants by our lab and others has shown Pol II activity-sensitive aspects 534 of transcription initiation, elongation, co-transcriptional processes, and termination [4, 12, 14, 18, 19, 51] . 535
In order to understand Pol II mechanisms and utilize Pol II mutants to probe co-transcriptional 536 processes, we require interrogation of hypotheses about elongation in vivo. Our current study utilizes a 537 set of yeast Pol II catalytic mutants to probe broad aspects of gene expression in vivo. Importantly, we 538 investigated two widely used transcriptional reporter assays and revealed critical limitations to each 539 assay, suggesting caution in their use and interpretation going forward. 540 541 .
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The copyright holder for this preprint (which was not . http://dx.doi.org/10.1101/072785 doi: bioRxiv preprint first posted online Aug. 31, 2016;  We show that Pol II catalytic defects lead to a decrease in overall Pol II occupancy with reduction in 3' 542 end occupancy on a galactose inducible reporter gene, GAL1p::YLR454w (Figure 1) . Further, using a 543 constitutively expressed TEF1p::YLR454w reporter we find that growth on different carbon sources 544 alters occupancy profiles for both WT Pol II and catalytic mutants (Figure 1) . Previously, several 545 observations suggested alteration of Pol II activity and gene expression due to external perturbations 546 such as carbon source or temperature [55, 56] . Likewise, environmental stress has also been shown to 547 affect Pol II activity and gene expression [80] . Notably, it has also been shown that RAS/PKA signaling 548 pathway, which controls aspects of glucose signaling, can target proteins associated with general 549 transcription machinery, can putatively regulate elongating Pol II by targeting Spt5/4 [81, 82] , and shows 550 interactions with Nab3/Nrd1 termination factors [83] . In addition to differential effects of carbon source on 551 steady state Pol II occupancy, we observed a differential 3'-end effect for the GOF mutant E1103G when 552 transcription was shut off by galactose starvation relative to shut off by addition of glucose ( Figure 5) . 553
Further, our data indicate that at least one tested GOF mutant, G1097D, is impaired in glucose 554 repression kinetics (Figure 7) . Taken together these results indicate growth condition-dependent 555 modulation Pol II elongation in vivo. Galactose induction of GAL genes is also defective in both LOF and 556 GOF mutants, with both classes showing impaired growth at 37˚C on galactose (Supplementary Figure  557  1B ). It is likely that temperature further exacerbates the already large defects in Pol II mutants seen for 558 highly expressed GAL genes and galactose-inducible reporters. Such defects likely arise from the sum 559 of a number of distinct individual defects in initiation, elongation, and termination. 560 561
Pol II E1103G, which was reported previously to be fast for elongation in vivo relative to WT, appears 562 slower than WT in our study. We have identified a possible artifact of prior experimental design that may 563 have contributed to discrepant results reported here from those reported elsewhere. First, we have 564 shown that galactose starvation, which will occur during washing of cells as described in Hazelbaker et 565 al, shows relatively fast kinetics of transcriptional shut off at GAL1p::YLR454w [18] . Second, GAL 566 promoter shut off by galactose starvation shows at least two differences in Pol II behavior compared to 567 inhibition by glucose. During galactose starvation, E1103G Pol II runs off both the 5' and 3' ends of the 568 reporter faster than WT ( Figure 5F ). 5' runoff is consistent with E1103G elongating faster than WT early 569 in the time course, or E1103G being more sensitive to galactose starvation. Increased runoff kinetics 570 from the 3' end of the reporter in E1103G is perplexing. This observation suggests that Pol II could be 571 differentially affected while on the 3' end of the gene relative to the middle under different growth 572 conditions. If elongation properties are expected to be uniform across a transcription unit, loss of Pol II 573 occupancy should occur in a polar fashion from 5' to 3', as is observed under glucose shut off conditions 574 for WT Pol II. Furthermore, after these early effects observed for E1103G relative to WT under galactose 575 starvation, E1103G Pol II shows a delay clearing the template at longer time points regardless of 576 mechanism of shutoff, just as purported LOF Pol II alleles do under glucose inhibition. 577 578
In vitro biochemical studies, including direct observations of individual polymerases at the single 579 molecule level, have repeatedly shown faster elongation rate for E1103G compared to WT [4, 6, 9, 11] . 580 Several lines of evidence suggest E1103G in vitro GOF activity manifests itself in vivo through 581 transcriptional effects distinct from LOF mutants. First, primer extension analysis shows that E1103G 582 shifts TSS usage upstream at a number of promoters, consistent with a model that increase in catalytic 583 activity increases initiation probability during Pol II promoter scanning, resulting in observed upstream 584 TSS shifts [4, 14] . Second, E1103G and other Pol II GOF mutants show allele-specific genetic 585 interactions with a number of factors, suggesting their defects are distinct from LOF mutants [14] . For 586 example, the synthetic sick genetic interaction of E1103G with the RNA processing factor alleles rat1-1 587 and xrn1∆/rat1-1, which are suppressed by LOF Pol II alleles, are consistent with exacerbation of 588 termination defects through faster elongation [17] [18] [19] 61] . 589 590
Delayed termination for E1103G was observed in Hazelbaker et al [18] through observation of increased 591 length of pre-processed snR33, which we reproduce (Figure 6 ). We further show that an even stronger 592
GOF mutant, G1097D, shows a corresponding increase in pre-processed snR33 length relative to 593 E1103G or WT. While these results are consistent with increased elongation rate, they are also 594 consistent with possible defective termination. As Pol II conformational changes, including those that 595 may occur with participation of the trigger loop, have been implicated in termination mechanisms, altered 596 termination probability should not be ruled out as possible mechanism [20] . Previous observations that 597 31, 2016; addition of 6-AU or shifting cells to higher temperature, which lead to apparent decreases or increases in 598 elongation rate, respectively, also decrease or increase pre-processed snR33 length, extended the 599 correlation between this assay and predicted elongation rate changes [18] . Finally, a recent study 600 demonstrated that an E1103G strain displays a shift in cotranscriptional splicing towards downstream 601 positions, consistent with Pol II traveling further prior to splicing (alternatively, splicing could be delayed) 602 [15] . Altogether, these data are consistent with increased elongation kinetics in GOF catalytic mutants in 603 vivo under a parsimonious view. We identify slow Mig1p nuclear translocation upon glucose exposure as 604 a possible explanation for delayed kinetics of Pol II clearance of GAL1p::YLR454w for the severe GOF 605 allele G1097D. There may be additional untested steps in inhibition specific to the GAL system that are 606 defective, or defects specific to the long YLR454w template for Pol II GOF strains. Regardless, careful 607 consideration of possible variables in assay behavior is urged given the results we present. 608 609
In order to exploit the existing transcription reporter systems to probe transcription mechanism carefully 610 we need a detailed understanding of each phenotypic system, such as our analyses to dissect the Spt Pol II GOF E1103G are likely to derive from initiation defects (Figure 10 ). 631 632
Our Pol II catalytic mutants and pre-mRNA processing factor genetic interaction data show allele-specific 633 genetic interactions (Figure 3) , as noted above. Synthetic sick interaction of GOF with xrn1∆ and 634 stabilization of GAL1p::YLR454w transcript in xrn1∆/rat1-1 double mutant background is suggestive of a 635 5'-end processing defect in GOF mutants, possibly a capping defect. A defect in capping would be 636 predicted to expose mRNA to the action of 5' exonucleases Xrn1 and Rat1. Capping of nascent 637 transcripts occurs co-transcriptionally and Pol II elongation has been proposed to be coupled with 638 successful capping, though a direct "capping checkpoint" has yet to be shown [85, 86] . Potential 639 sensitivity of capping to Pol II GOF mutants is suggestive of either a defective checkpoint in Pol II mutant 640 strains or the absence of one. We also observe correlations of reporter transcript half-life with expression 641 levels in Pol II mutants, and with Pol II mutants' growth defects (Figure 4) . Although we tested a single 642 transcript, mRNA decay rate correlation with growth rate is consistent with recent findings [26, 27] . As 643 growth efficiency can be directly connected the overall translation demand, our observation is consistent 644 with the proposed 'feed-back' of gene expression control between transcription rate and mRNA decay 645 occurring through alteration of overall translational rate, as mRNA decay happens co- rate between WT and fast catalytic mutant (E1103G) following Hazelbaker et al., protocol [18] . Pre-944 glucose sample (0 min) was isolated as described in Figure 5A ; subsequently cells were washed in 945 synthetic complete media lacking carbon source and inoculated in YPD (4% dextrose) to shut off the 946 transcription. One wash 0 (W0 min) sample was isolated after the washing and before shut off to 947 determine the effect of washing. Values normalized to pre-glucose addition (0 min) and error bars 948 represent standard deviation of the mean of at least three independent repeats. (F) Galactose depletion 949 to determine apparent elongation rate in WT and fast catalytic mutant (E1103G). Pre-glucose and (0 950 min) and wash 0 (W0 min) samples were taken as described in Fig 5G, followed by inoculation of cells 951 . CC-BY-NC-ND 4.0 International license peer-reviewed) is the author/funder. It is made available under a The copyright holder for this preprint (which was not . http://dx.doi.org/10.1101/072785 doi: bioRxiv preprint first posted online Aug. 31, 2016;  into synthetic media lacking any carbon to incur transcriptional shutoff in absence of any sugar. Values 952 normalized to pre-glucose addition (0 min) and error bars represent standard deviation of the mean for at 953 least three independent repeats. 954
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